These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2994563)

  • 1. Feline calicivirus subunit vaccine--a prototype.
    Komolafe OO; Jarrett O
    Antiviral Res; 1985 Aug; 5(4):241-8. PubMed ID: 2994563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the immunogenicity of attenuated feline calicivirus vaccines by ELISA.
    Lau RC; Halliday AJ; Davies H
    Vet Microbiol; 1992 Jun; 31(2-3):139-46. PubMed ID: 1320788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody and cell-mediated immune responses to feline calicivirus following inactivated vaccine and challenge.
    Tham KM; Studdert MJ
    Zentralbl Veterinarmed B; 1987 Nov; 34(9):640-54. PubMed ID: 2830748
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of an inactivated feline calicivirus (FCV) vaccine against challenge with United Kingdom field strains and its interaction with the FCV carrier state.
    Gaskell CJ; Gaskell RM; Dennis PE; Wooldridge MJ
    Res Vet Sci; 1982 Jan; 32(1):23-6. PubMed ID: 6283611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tri-combinant vaccine for feline herpesvirus, calicivirus and panleukopenia virus infections in Japanese native cats.
    Yagami K; Furukawa T; Fukui M; Hamada H
    Jikken Dobutsu; 1985 Jul; 34(3):287-94. PubMed ID: 2998830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine.
    Scott FW
    Am J Vet Res; 1977 Feb; 38(2):229-34. PubMed ID: 190925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of an inactivated vaccine for the prevention of rhinotracheitis, caliciviral disease, and panleukopenia in cats.
    Povey RC; Koonse H; Hays MB
    J Am Vet Med Assoc; 1980 Aug; 177(4):347-50. PubMed ID: 6256329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of primary-stage feline immunodeficiency virus infection on subsequent feline calicivirus vaccination and challenge in cats.
    Dawson S; Smyth NR; Bennett M; Gaskell RM; McCracken CM; Brown A; Gaskell CJ
    AIDS; 1991 Jun; 5(6):747-50. PubMed ID: 1652980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1978 Sep; 103(10):200-2. PubMed ID: 212859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline caliciviral disease: experimental immunoprophylaxis.
    Kahn DE; Hoover EA
    Am J Vet Res; 1976 Mar; 37(3):279-83. PubMed ID: 1259224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
    Rong S; Lowery D; Floyd-Hawkins K; King V
    Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year duration of immunity in cats following vaccination against feline rhinotracheitis virus, feline calicivirus, and feline panleukopenia virus.
    Gore TC; Lakshmanan N; Williams JR; Jirjis FF; Chester ST; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):213-22. PubMed ID: 17039444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of an intranasal combined feline viral rhinotracheitis, feline calicivirus vaccine and the FVR carrier state.
    Orr CM; Gaskell CJ; Gaskell RM
    Vet Rec; 1980 Feb; 106(8):164-6. PubMed ID: 6244692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study.
    Spiri AM; Novacco M; Meli ML; Stirn M; Riond B; Fogle JE; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
    Viruses; 2021 Aug; 13(9):. PubMed ID: 34578316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
    Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
    Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of feline calicivirus antigens in the joints of infected cats.
    Bennett D; Gaskell RM; Mills A; Knowles J; Carter S; McArdle F
    Vet Rec; 1989 Apr; 124(13):329-32. PubMed ID: 2541528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline viral respiratory disease. The carrier state, vaccination, and control.
    August JR
    Vet Clin North Am Small Anim Pract; 1984 Nov; 14(6):1159-71. PubMed ID: 6097007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of two commercial feline rhinotracheitis-calicivirus-panleukopenia vaccines.
    Povey RC
    Can Vet J; 1979 Oct; 20(10):253-60. PubMed ID: 232426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
    Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
    Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of immunity in kittens after vaccination with a non-adjuvanted vaccine against feline panleucopenia, feline calicivirus and feline herpesvirus.
    Jas D; Aeberlé C; Lacombe V; Guiot AL; Poulet H
    Vet J; 2009 Oct; 182(1):86-93. PubMed ID: 18694649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.